Professor Stéphane Oudard, oncologist and Professor Arnaud Méjean, urological surgeon, at the Georges Pompidou European Hospital, describe how advances in personalized medicine are changing their practices in the treatment of urological cancers.

Acute Myeloid Leukemia: identification of a new targeted therapy approach
Acute myeloid leukemia (AML) is a hematologic malignancy that develops from hematopoietic stem
